Wuxi Biologics (Cayman) (HK:2269) has released an update.
Wuxi Biologics (Cayman) Inc. has announced the approval of a restricted share grant, awarding 434,227 shares to nine employees at no cost, with a vesting period extending over five years. The shares will vest in increments, with a clawback mechanism in place for cases of misconduct or termination for cause. This grant aims to incentivize employees by aligning their interests with the company’s performance and does not include additional performance targets.
For further insights into HK:2269 stock, check out TipRanks’ Stock Analysis page.
